This brand name is authorized in Japan.
The drug MEDLENIK contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
U38V3ZVV3V - FERRIC CHLORIDE
|
2
|
UNII
QQE170PANO - MANGANESE CHLORIDE
|
Manganese is required for the synthesis of the mucopolysaccharides of cartilage, glucose utilisation, steroid biosynthesis and for the activity of pyruvate carboxylase. It is bound to arginase of the liver and activates many enzymes. |
|
3
|
UNII
89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
|
4
|
UNII
LRX7AJ16DT - CUPRIC SULFATE
|
5
|
UNII
1C4QK22F9J - POTASSIUM IODIDE
|
Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
JP | 医薬品医療機器総合機構 | 3229501A1060, 3229501G1046 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.